Long-term follow-up of patients with Kawasaki disease

Progress in Pediatric Cardiology

Volumn 6, Issue 3, 1997, Pages 227-236

  Takahashi, Masato ^a   Mason, Wilbert H ^b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anticoagulation; Coronary artery aneurysm; Coronary artery bypass graft; Myocardial ischemia; Myocardial perfusion scintigraphy; Stress testing

Indexed keywords

ACETYLSALICYLIC ACID; DOBUTAMINE; WARFARIN;

ANGIOCARDIOGRAPHY; ARTICLE; CHILD; CORONARY ARTERY ANEURYSM; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; DIAGNOSTIC VALUE; DRUG EFFICACY; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE ELECTROCARDIOGRAPHY; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEART SCINTISCANNING; HUMAN; INTRAVASCULAR ULTRASOUND; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0030899340     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(97)00194-X     Document Type: Article

References (53)

1. Takahashi M, Mason W, Lewis AB. Regression of coronary aneurysms in children with Kawasaki syndrome. Circulation 1987;75:387-394.
2. Akagi T, Rose V, Benson LN, Newman A, Freedom RM. Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 1992;121:689-694.
3. Nakano H, Ueda K, Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 1985;56:846-851.
4. Tatara K, Kusakawa S. Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study. J Pediatr 1987;111:705-710.
5. Naoe S, Takahashi K, Masuda H, Tanaka N. Coronary findings post Kawasaki disease in children who died of other causes. In: Shulman ST, editor. Kawasaki disease. New York: Alan R Liss, 1987:341-346.
6. Spevak PJ, Newburger JW, Keane J, Selwyn A, Takahashi M Reactivity of coronary arteries in Kawasaki syndrome: an analysis of function. Am J Cardiol 1987;60:640. Abstract.
7. Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr 1992;121:684-688.
8. Suzuki A, Arakaki Y, Sugiyama H, Ono Y, Yamagishi M, Kimura K, Kamiya T. Observation of coronary arterial lesion due to Kawasaki disease by intravascular ultrasound. In: Kato H, editor. Kawasaki disease: proceeding of the 5th International Kawasaki disease symposium, Fukuoka, Japan, 22-25 May 1995, Amsterdam; Elsevier, 1995;451-459.
9. Sugimura T, Kato H, Inoue O et al. Intravascular ultrasound of coronary arteries in children: assessment of the wall morphology and the lumen after Kawasaki disease. Circulation 1994;89:258-265.
10. Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid profiles after Kawasaki syndrome. Circulation 1991;84:625-631.
11. Fulton DR, Meissner C, Peterson MB. Effects of current therapy of Kawasaki disease on eicosanoid metabolism. Am J Cardiol 1988;61:1323-1327.
12. Dajani AS, Taubert KA, Takahashi M et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation 1994;89:916-922.
13. Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analysis of 195 cases. J Pediatr 1986;108:923-927.
14. Takahashi M, Mason W. Can echocardiogram predict coronary artery angiographic findings: aneurysm size, thrombosis, and stenosis? In: Takahashi M and Taubert K, editors. Proceedings of the Fourth International Symposium on Kawasaki Disease. Dallas: American Heart Association, 1993;336-341.
15. Pahl E, Ettedgui J, Neches WH, Park SC. The value of angiography in the follow-up of coronary involvement in mucocutaneous lymph node syndrome (Kawasaki disease). J Am Coll Cardiol 1989;14:1318-1325.
16. Noto N Ayusawa M, Karasawa H, Yamaguchi H, Harada K. Combination of dobutamine stress and myocardial contrast echocardiography. In: Kato H, editor. Kawasaki disease: proceeding of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, 22-25 May 1995. Amsterdam: Elsevier, 1995;466-471.
17. Rhodes J, Hijazi ZM, Marx GR, Fulton DR. Aerobic exercise function of patients with persistent coronary artery aneurysms secondary to Kawasaki disease. Pediatr Cardiol 1996;17:226-230.
18. Beller GA. Pharmacological stress imaging. JAMA 1991;265:633-638.
19. Hansen TH, Segar DS. The use of dobutamine stress echocardiography for the determination of myocardial viability Clin Cardiol 1996;19:607-612.
20. Gianrossi R, Detrano R, Mulvihill D et al. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 1989;80:87-98.
21. Tomita H, Futaki S, Saito I. ST changes on treadmill exercise test for children with coronary stenotic lesions. J Jpn Pediatr Soc 1986;90:1104-1109.
22. Beleslin BD, Ostojic M, Stepanovic J et al. Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 1994;90:1168-1176.
23. Hansen TH, Segar DS. The use of dobutamine stress echocardiography for the determination of myocardial viability. Clin Cardiol 1996;19:607-612.
24. Noto N, Ayusawa M, Karasawa K, Yamaguchi H, Sumitomo N, Okada T, Harada K. Dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease. J Am Coll Cardiol 1996;27:1251-1256.
25. Strauss HW, Zaret BL, Martin ND, Wells HP, Flamm MD. Non-invasive evaluation of regional myocardial perfusion with potassium-43: technique in patients with exercise-induced transient myocardial ischemia. Radiology 1973;108:85.
26. Maddahi J, Garcia EV, Berman DS, Waxman A, Swan HJC, Forrester J. Improved non-invasive assessment of regional stress myocardial uptake and washout of thallium-201. Circulation 1981;64:924-935.
27. Sinusas AJ. The Quinn essay: cardiac imaging with technetium-99m labelled perfusion agents. In: Hoffer PB, Gore JC, Verani MS, editors. Yearbook of Nuclear Medicine. Chicago: Mosby, 1992;15-46.
28. Diamond GA. How accurate is SPECT thallium scintigraphy? J Am Col Cardiol 1990;16:1017-1021.
29. Mishkin F. The diagnostic process and nuclear medicine In: Alazraki N and Mishkin F, editors. Fundamentals of Nuclear Medicine, second edition. New York; Society of Nuclear Medicine, 1988;21-31.
30. Fukuda T. Myocardial ischemia in Kawasaki disease; evaluation by dipyridamole stress thallium-201 (TI-201) myocardial imaging and exercise test. Kurume Med J 1992;39:245-255.
31. Kondo C, Nakanishi T, Sonobe T, Tatara K, Momma K, Kusakabe K. Scintigraphic monitoring of coronary artery occlusions due to Kawasaki disease. Am J Cardiol 1993;71:681-685.
32. Hijazi ZM, Udelson JE, Snapper H et al. Physiologic significance of chronic coronary aneurysms in patients with Kwasaki disease. J Am Coll Cardiol 1994;24:1633-1638.
33. Paridon SM, Galioto FM, Vincent JA, Tomassoni TL, Sullivan NM, Bricker TJ. Exercise capacity and incidence of myocardila perfusion defects after Kawasaki disease in children and adolescents. J Am Coll Cardiol 1995;25:1420-1424.
34. Fukazawa M, Fukushige J, Takeuchi T et al. Discordance between Thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram. Pediatr Cardiol 1993;14:67-74.
35. Takahashi M, Shimada H, Billingham M, Mason W, Miller JH. Electron microscopic findings of myocardial biopsy correlated with perfusion scan and coronary angiography in chronic Kawasaki syndrome: myocellular ischemia possibly due to microvasculopathy. In: Kato H, editor. Kawasaki disease: proceeding of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, 22-25 May 1995. Amsterdam: Elsevier, 1995;401-410.
36. Yoshibayashi M, Tamaki N, Nishioka K et al. Regional myocardila perfusion and metabolism assessed by positron emission tomography in children with Kawasaki disease and significance of abnormal Q waves and their disappearance. Am J Cardiol 1991;68:1638-1645.
37. Uemura S, Hirayama K, Suzuki H et al. Coronary angiography and segmented cine MRI in a single breath-hold to detect the coronary artery aneurysm following Kawsaki disease. In: Kato H, editor. Kawasaki disease: proceeding of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, 22-25 May 1995. Amsterdam: Elsevier, 1995;531-538.
38. Fujiwara M, Yoshibayashi M, Ono Y et al. Usefulness of UFCT to detect myocardial damage due to stenostic lesion. Ibid: 494-497.
39. Kurosaki K, Yoshibayashi M, Suzuki A, Kamiya T, Naito H. Wall abnornmality of apparently normal coronary artery after Kawasaki disease. Ibid: 489-493.
40. Noto N, Ayusawa M, Karasawa K, Yamaguchi H, Harada K. Combination of dobutamine and myocardial contrast echocardiography in Kawasaki disease. Ibid: 466-471.
41. Yamada K. Blood platelet disorders and thrombotic tendencies associated with Kawasaki disease. Jpn J Clin Med 1983;41:2097-2102.
42. Inamo Y, Harada K. Increase of tissue factor and haemodynamic molecular markers in Kawasaki disease. Ibid: 269-271.
43. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med 1995;149:779-783.
44. Suzuki A, Kamiya T, Ono Y, Kuroe K. Follow-up study of coronary arterial lesions caused by Kawasaki disease. In: Takahashi M and Taubert K, editors. Proceedings of the Fourth International Symposium on Kawasaki Disease. Dallas: American Heart Association, 1993;317-323.
45. Suzuki A, Kamiya T, Tsuda E, Tsukano S. Natural history of coronary artery lesions in Kawasaki disease. Progress Pediatr Cardiol 1996;current issue pp??.
46. Nicholas WL, Bowie EJW. Standardization of the prothrombin time for monitoring orally administered anticoagulant therapy with use of the international normalized ratio system. Mayo Clin Proc 1993;68:897-898.
47. Burtt DM, Pollack P, Bianco JA. Intravenous streptokinase in an infant with Kawasaki disease complicated by acute myocardial infarction. Pediatr Cardiol 1986;6:307-311.
48. Kato H, Ichinose E, Inoue O, Akagi T. Intracoronary thrombolytic therapy in Kawasaki disease. In: Shulman ST, editor. Kawasaki disease. New York: Alan Liss, 1987:445-454.
49. Sonobe T, Kataoka T, Tsuchiya K et al. Intravenous coronary thrombolysis using recombinant tissue plasminogen activator for intra-aneurysmal thrombi in Kawasaki disease. In: Takahashi M and Taubert K, editors. Proceedings of the Fourth International Symposium on Kawasaki Disease. Dallas: American Heart Association, 1993:363-364.
50. Akimoto K, Okubo M, Nishimoto K et al. Percutaneous transluminal coronary angioplasty in Kawasaki disease: five case reports and literature review. In: Kato H, editor. Kawasaki disease: proceeding of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, 22-25 May 1995. Amsterdam: Elsevier, 1995;507-512.
51. Kitamura S, Kameda Y, Seki T, Kawachi K et al. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg 1994;107:663-673.
52. Checchia P, Pahl E, Rosenfeld E, Radley-Smith R, Shulman ST. The worldwide experience with cardiac transplantation for Kawasaki disease. In: Kato H, editor. Kawasaki disease: proceeding of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, 22-25 May 1995. Amsterdam: Elsevier, 1995;522-526.
53. Takahashi M, Mason W, Thomas D, Sinatra F. Reye syndrome following Kawasaki syndrome confirmed by liver histopathology. Ibid: 436-446.